X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3805) 3805
Book Review (476) 476
Publication (364) 364
Magazine Article (22) 22
Book Chapter (18) 18
Dissertation (6) 6
Conference Proceeding (3) 3
Book / eBook (2) 2
Data Set (1) 1
Paper (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3419) 3419
humans (2654) 2654
malaria (2110) 2110
male (1502) 1502
female (1471) 1471
animals (1415) 1415
artemisinin (1328) 1328
antimalarials - therapeutic use (1269) 1269
antimalarials - administration & dosage (1242) 1242
artemisinins - administration & dosage (1223) 1223
artemisinins - therapeutic use (1114) 1114
malaria, falciparum - drug therapy (1081) 1081
tropical medicine (1055) 1055
infectious diseases (1044) 1044
parasitology (1003) 1003
artesunate (979) 979
parasitic diseases (962) 962
adult (922) 922
research (877) 877
malaria - drug therapy (848) 848
drug therapy, combination (787) 787
child, preschool (735) 735
plasmodium falciparum (734) 734
child (712) 712
drug combinations (704) 704
antimalarials (700) 700
pharmacology & pharmacy (682) 682
adolescent (677) 677
drug resistance (664) 664
drug therapy (648) 648
artemisinins - pharmacology (638) 638
antimalarials - pharmacology (629) 629
plasmodium falciparum - drug effects (612) 612
treatment outcome (611) 611
artemisinins (610) 610
children (592) 592
infant (575) 575
artemether (539) 539
parasites (539) 539
middle aged (525) 525
mice (519) 519
health aspects (485) 485
drugs (465) 465
sesquiterpenes - administration & dosage (429) 429
plasmodium-falciparum (424) 424
sesquiterpenes - therapeutic use (423) 423
antimalarials - pharmacokinetics (421) 421
dihydroartemisinin (421) 421
plasmodium-falciparum malaria (416) 416
antimalarials - adverse effects (413) 413
artemether-lumefantrine (409) 409
vector-borne diseases (409) 409
analysis (407) 407
efficacy (407) 407
infectious and parasitic diseases (407) 407
arctic medicine. tropical medicine (390) 390
care and treatment (387) 387
public health (387) 387
young adult (387) 387
pharmacokinetics (386) 386
chloroquine (379) 379
public, environmental & occupational health (371) 371
malaria, falciparum - parasitology (368) 368
artemisinins - adverse effects (361) 361
dosage and administration (349) 349
resistance (343) 343
medicine (340) 340
administration, oral (329) 329
in-vitro (309) 309
abridged index medicus (308) 308
microbiology (308) 308
artemisinins - pharmacokinetics (306) 306
mefloquine (301) 301
drug dosages (292) 292
infections (283) 283
studies (282) 282
fluorenes - therapeutic use (273) 273
artemisinin resistance (269) 269
fluorenes - administration & dosage (263) 263
research article (263) 263
ethanolamines - therapeutic use (262) 262
dose-response relationship, drug (261) 261
ethanolamines - administration & dosage (252) 252
rats (246) 246
malaria, falciparum - epidemiology (242) 242
usage (238) 238
therapy (237) 237
medicine, general & internal (235) 235
aged (234) 234
clinical trials (231) 231
derivatives (229) 229
erythrocytes (229) 229
sulfadoxine-pyrimethamine (227) 227
quinine (224) 224
time factors (224) 224
immunology (222) 222
medical research (219) 219
chemotherapy (216) 216
pharmacology (216) 216
thailand (216) 216
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3729) 3729
Chinese (60) 60
French (33) 33
German (6) 6
Japanese (5) 5
Portuguese (3) 3
Spanish (3) 3
Dutch (2) 2
Russian (2) 2
Danish (1) 1
Italian (1) 1
Korean (1) 1
Norwegian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Landier, Jordi and Parker, Daniel M and Thu, Aung Myint and Lwin, Khine Shwe War and Lwin, Khin Maung and Delmas, Gilles and Nosten, Suphak and Nosten, François H and Andolina, Chiara and Aguas, Ricardo and Ang, Saw Moe and Aung, Ei Phyo and Baw, Naw Baw and Be, Saw Aye and B'Let, Saw and Bluh, Hay and Bonnington, Craig A and Chaumeau, Victor and Chirakiratinant, Miasa and Cho, Win Cho and Christensen, Peter and Corbel, Vincent and Day, Nicholas PJ and Dah, Saw Hsa and Dhorda, Mehul and Dondorp, Arjen M and Gaudart, Jean and Gornsawun, Gornpan and Haohankhunnatham, Warat and Hla, Saw Kyaw and Hsel, Saw Nay and Htoo, Gay Nay and Htoo, Saw Nay and Imwong, Mallika and John, Saw and Kajeechiwa, Ladda and Kereecharoen, Lily and Kittiphanakun, Praphan and Kittitawee, Keerati and Konghahong, Kamonchanok and Khin, Saw Diamond and Kyaw, Saw Win and Ling, Clare and Ma, Naw K' Yin and Marie, Alexandra and Maung, Cynthia and Marta, Ed and Minh, Myo Chit and Miotto, Olivo and Moo, Paw Khu and Moo, Merry and Moo, Ku Ler and Na, Naw Na and Nay, Mar and Nyo, Slight Naw and Oh, Eh Kalu Shwe and Oo, Tun Pyit and Oo, Phu Thit and Paw, Eh Shee and Phumiya, Choochai and Phyo, Aung Pyae and Pilaseng, Kasiha and Proux, Stéphane and Rakthinthong, Santisuk and Ritwongsakul, Wannee and Salathibuphha, Kloloi and Santirad, Armon and Sawasdichai, Sunisa and von Seidlein, Lorenz and Shee, Paw Bway and Shee, Paw Wah and Tangseefa, Decha and Thwin, May Myo and Tun, Saw Win and Wanachaloemlep, Chode and White, Lisa J and White, Nicholas J and Wiladphaingern, Jacher and Win, Saw Nyunt and Yee, Nan Lin and Yuwapan, Daraporn and Malaria Elimination Task Force Grp and Malaria Elimination Task Force Group
The Lancet, ISSN 0140-6736, 05/2018, Volume 391, Issue 10133, pp. 1916 - 1926
Potentially untreatable malaria threatens the Greater Mekong subregion. A previous series of pilot projects in Myanmar, Laos, Cambodia, and Vietnam suggested... 
RESISTANCE | MEDICINE, GENERAL & INTERNAL | AREA | SPREAD | EPIDEMIOLOGY | Prevalence | State Medicine | Artemether, Lumefantrine Drug Combination | Humans | Fluorenes - therapeutic use | Male | Ethanolamines - administration & dosage | Primaquine - administration & dosage | Incidence | Rural Population | Malaria, Falciparum - diagnosis | Malaria, Falciparum - epidemiology | Female | Fluorenes - administration & dosage | Drug Resistance | Malaria, Falciparum - drug therapy | Artemisinins - administration & dosage | Treatment Outcome | Antimalarials - therapeutic use | Artemisinins - therapeutic use | Antimalarials - administration & dosage | Mass Drug Administration - methods | Primaquine - therapeutic use | Myanmar - epidemiology | Ethanolamines - therapeutic use | Early Diagnosis | Drug Combinations | Plasmodium falciparum | Diagnosis | Malaria | Analysis | Intervention | Dihydroartemisinin | Vector-borne diseases | Medical research | Primaquine | Hot spots | Artemisinin | Parasites | Dosage | Medical diagnosis | Molecular chains | Surveys | Charities | Tuberculosis | Acquired immune deficiency syndrome--AIDS | Villages | Artemether | Histocompatibility antigen HLA | Adults | Diagnostic systems | Genotypes | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Santé publique et épidémiologie | Infectious diseases
Journal Article
Journal Article
Journal of Pharmacy and Pharmacology, ISSN 0022-3573, 11/2017, Volume 69, Issue 11, pp. 1437 - 1446
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 04/2015, Volume 79, Issue 4, pp. 636 - 649
Journal Article
The International Journal of Health Planning and Management, ISSN 0749-6753, 01/2013, Volume 28, Issue 1, pp. 102 - 121
This paper reports on a study, which assessed coverage with malaria control interventions in rural Burkina Faso, namely insecticide‐treated mosquito nets (ITN)... 
malaria control | intermittent preventive treatment for pregnant women (IPTp) | insecticide‐treated nets (ITNs) | Burkina Faso | artemisinin‐based combination therapy (ACT) | Insecticide-treated nets (ITNs) | Artemisinin-based combination therapy (ACT) | Intermittent preventive treatment for pregnant women (IPTp) | Malaria control | CONTROLLED-TRIAL | DEMOGRAPHIC SURVEILLANCE | UNCOMPLICATED FALCIPARUM-MALARIA | insecticide-treated nets (ITNs) | HOME MANAGEMENT | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | INTERMITTENT PREVENTIVE TREATMENT | NET OWNERSHIP | ARTEMISININ COMBINATION THERAPY | PREGNANT-WOMEN | HEALTH POLICY & SERVICES | HEALTH-CARE | artemisinin-based combination therapy (ACT) | YOUNG-CHILDREN | Healthcare Disparities - statistics & numerical data | Humans | Artemisinins - administration & dosage | Child, Preschool | Infant | Antimalarials - therapeutic use | Universal Coverage - organization & administration | Socioeconomic Factors | Malaria - prevention & control | Pregnancy | Rural Health Services - organization & administration | Young Adult | Artemisinins - therapeutic use | Antimalarials - administration & dosage | Adolescent | Adult | Female | Mosquito Nets | Program Evaluation | Drug Therapy, Combination | Child | Disease prevention | Insurance coverage | Regression analysis | Malaria | Disease control | Socioeconomic factors | Health administration
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 12/2007, Volume 45, Issue 11, pp. 1453 - 1461
Background. Combination antimalarial therapy is advocated to improve treatment efficacy and limit selection of drug-resistant parasites. We compared the... 
Medical treatment failures | Relapse | Malaria | Vomiting | Articles and Commentaries | Antimalarials | Infections | Parasites | Parasitemia | Falciparum malaria | Fever | ANTIMALARIAL-DRUG | INFECTIOUS DISEASES | EFFICACY | COMBINATION THERAPY | MICROBIOLOGY | MEFLOQUINE | IMMUNOLOGY | CHLOROQUINE | CHILDREN | TRIAL | VIVAX MALARIA | TOLERABILITY | ARTESUNATE | Ethanolamines - adverse effects | Humans | Fluorenes - therapeutic use | Child, Preschool | Sulfadoxine - administration & dosage | Male | Sulfadoxine - adverse effects | Quinolines - administration & dosage | Ethanolamines - administration & dosage | Plasmodium falciparum | Pyrimethamine - administration & dosage | Sulfadoxine - therapeutic use | Amodiaquine - adverse effects | Female | Fluorenes - administration & dosage | Fluorenes - adverse effects | Amodiaquine - therapeutic use | Drug Therapy, Combination | Child | Pyrimethamine - therapeutic use | Antimalarials - adverse effects | Malaria, Falciparum - drug therapy | Pyrimethamine - adverse effects | Artemisinins - administration & dosage | Antimalarials - therapeutic use | Amodiaquine - administration & dosage | Animals | Artemisinins - therapeutic use | Burkina Faso | Antimalarials - administration & dosage | Ethanolamines - therapeutic use | Quinolines - therapeutic use | Artemisinins - adverse effects | Drug Combinations | Quinolines - adverse effects | Demographic aspects | Dosage and administration | Drug therapy, Combination | Drug therapy | Comparative analysis | Health aspects | Clinical trials | Bacteria | Nonsteroidal anti-inflammatory drugs | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2009, Volume 361, Issue 5, pp. 455 - 467
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 04/2016, Volume 62, Issue 8, pp. 964 - 971
Background. Artemisinins, which are derived from plants, are subject to risk of supply interruption due to climatic changes. Consequently, an effort to... 
artemisinin combination therapy | arterolane maleate | malaria | once-daily dose | fixed-dose combination | INFECTIOUS DISEASES | MULTICENTER | CLINICAL-TRIAL | EFFICACY | SAFETY EVALUATION | MICROBIOLOGY | IMMUNOLOGY | COMBINATION | CHILDREN | PHARMACOKINETICS | DIHYDROARTEMISININ-PIPERAQUINE | PLASMODIUM-FALCIPARUM | Africa - epidemiology | Peroxides - administration & dosage | Humans | Middle Aged | Fluorenes - therapeutic use | Half-Life | Spiro Compounds - administration & dosage | Male | Spiro Compounds - therapeutic use | Peroxides - therapeutic use | Plasmodium falciparum - drug effects | Quinolines - administration & dosage | Ethanolamines - administration & dosage | Heterocyclic Compounds, 1-Ring - administration & dosage | Young Adult | Malaria, Falciparum - epidemiology | Adult | Female | Fluorenes - administration & dosage | Drug Therapy, Combination | Child | Malaria, Falciparum - drug therapy | Double-Blind Method | Artemisinins - administration & dosage | India - epidemiology | Antimalarials - therapeutic use | Malaria, Falciparum - parasitology | Asia - epidemiology | Artemisinins - therapeutic use | Antimalarials - administration & dosage | Adolescent | Heterocyclic Compounds, 1-Ring - therapeutic use | Ethanolamines - therapeutic use | Aged | Quinolines - therapeutic use | Plasmodium falciparum | Youth | Adults | Teenagers | Research | Health aspects | Polymerase chain reaction | Phosphates | Parasitic protozoa | Malaria | Risk assessment | Index Medicus | and Commentaries
Journal Article
Malaria Journal, ISSN 1475-2875, 01/2019, Volume 18, Issue 1, pp. 28 - 28
Background: Artemisinin-based combination therapy (ACT) is the recommended treatment against uncomplicated Plasmodium falciparum infections, and ACT is widely... 
Host-searching | Post-treatment transmission | Olfaction | Gametocytes | Antimalarial medication | Epidemiology | Skin odour |